# Novel Skin Care for Immunotherapy- Related Dermatologic Toxicities

> **NCT04929834** · NA · UNKNOWN · sponsor: **Jessa Hospital** · enrollment: 100 (estimated)

## Conditions studied

- Skin Toxicity
- Immunotoxicity

## Interventions

- **OTHER:** Hydrating emollient + body lotion for immunotherapy-related side effects

## Key facts

- **NCT ID:** NCT04929834
- **Lead sponsor:** Jessa Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-10-20
- **Primary completion:** 2023-12
- **Final completion:** 2023-12
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2023-02-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04929834

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04929834, "Novel Skin Care for Immunotherapy- Related Dermatologic Toxicities". Retrieved via AI Analytics 2026-07-04 from https://api.ai-analytics.org/clinical/NCT04929834. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*